Select Page

Press Releases

Sign up to get full access to all our latest Press Releases

Rapid Dose Therapeutics and Thrive Cannabis Sign Manufacturing Agreement for Quickstrip™ Cannabis Products

August 8, 2019


Burlington, ON, Brantford, ON, August 8, 2019 — Rapid Dose Therapeutics Corp. (CSE: DOSE), (“RDT”) announced today that they have signed a Manufacturing Agreement (“the Agreement”) with Thrive Cannabis (“Thrive”) to produce QuickStrip™ cannabis products for both the Canadian medical and recreational markets.  This Agreement...

Rapid Dose Therapeutics Expands Agreement for Quickstrip™ Nutraceutical Product Line in Eastern Europe and Increases Purchase Order to US$4.0 Million

August 1, 2019


Burlington, ON, August 1,  2019 — Rapid Dose Therapeutics Corp. (CSE: DOSE), (“RDT”) announced today that they have signed an amendment to the 12 month distribution  agreement (the “Agreement”) with Ukraine Pharma to expand the marketing and distribution of QuickStrip™ nutraceutical products to seven additional...

Rapid Dose Reports First Quarter Fiscal 2020 Financial Results and Provides Operations Update

July 30, 2019


BURLINGTON, Ontario – July 30, 2019 – Rapid Dose Therapeutics Corp. (“RDT”) (CSE: DOSE) today reported its financial results for the first quarter of fiscal 2020, which ended on May 31, 2019. “This quarter represents a very exciting milestone for RDT as we commence the...

Rapid Dose Therapeutics Completes Quickstrip™ Equipment Installation at Flower One Resulting in Immediate Revenue Generation

July 25, 2019


BURLINGTON, Ontario – July 25, 2019 – Rapid Dose Therapeutics Corp. (“RDT”) (CSE: DOSE) announced today that they have completed the last phase of the Managed Strip Services Agreement (the “Agreement”) signed in January 2019 with Flower One Holdings Inc. (“Flower One”) (CSE: FONE) (OTCQX:...

Rapid Dose Therapeutics Signs Distribution Agreement for Quickstrip™ Nutraceutical Product Line and Receives US$2.1 Million Purchase Order

July 16, 2019


Burlington, ON, July 16, 2019 — Rapid Dose Therapeutics Corp. (CSE: DOSE), (“RDT”) and Ukraine Pharma (the “Company”) announced today that they have signed a twelve month distribution  agreement (the “Agreement”) to export QuickStrip™ nutraceutical products to Ukraine and a number of other Eastern European...

Rapid Dose Therapeutics and Chemesis to Introduce Innovative Quickstrip™ Oral Thin Strips to the Michigan Cannabis Market

June 27, 2019


Burlington, ON and Vancouver, BC, June 27, 2019 — Rapid Dose Therapeutics Corp. (CSE: DOSE), (“RDT”) and Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company”) announced today that they have expanded the scope of their previously announced agreement (the “Agreement”) expanding the...

Rapid Dose Therapeutics Announces Commercialization of Quickstrip™ Oral Thin Strips

June 13, 2019


Licensee, Chemesis International Inc., begins efforts for distribution of QuickStrip™ across United States & Puerto Rico BURLINGTON, Ontario – June 13, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient...

Rapid Dose Therapeutics Appoints Vice President, Research & Innovation

June 6, 2019


BURLINGTON, Ontario – June 6, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian leader in drug delivery solutions,  is pleased to announce that Dr. Rina Carlini has been appointed Vice President, Research & Innovation. Dr. Carlini is an accomplished...

Rapid Dose Therapeutics and TFB & Associates Ltd. Sign Agreement for the Sale and Distribution of Innovative Quickstrip™ Nutraceutical Product Line Across Canada

April 16, 2019


BURLINGTON, Ontario – April 16, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has signed a Distribution Agreement with TFB & Associates...

Rapid Dose Therapeutics Appoints Chief Financial Officer and Provides Business Update

April 10, 2019


BURLINGTON, Ontario – April 10, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian leader in drug delivery solutions, is pleased to announce that Mr. Ian Fodie has been appointed Chief Financial Officer effectively immediately. Mr. Fodie replaces Mr. Lino...

1 2 3 4 5 6 7 8 9